Addex Therapeutics Ltd (SWX:ADXN)
Switzerland · Delayed Price · Currency is CHF 0.0560
-0.0026 (-4.44%)
At close: Nov 28, 2025
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of 6.23 million as of November 28, 2025. Its market cap has decreased by -0.97% in one year.
Market Cap
6.23M
Enterprise Value
3.97M
Revenue
167.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from 398.65M to 6.23M, a decrease of -98.44%. That is a compound annual growth rate of -20.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 6.23M | 10.77% |
| Dec 30, 2024 | 5.62M | -9.01% |
| Dec 29, 2023 | 6.18M | -40.48% |
| Dec 30, 2022 | 10.39M | -73.65% |
| Dec 30, 2021 | 39.42M | -25.96% |
| Dec 30, 2020 | 53.24M | 22.57% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 263.32B |
| Novartis AG | 200.48B |
| Lonza Group AG | 38.40B |
| Galderma Group AG | 37.98B |
| Alcon | 31.41B |
| Sandoz Group AG | 24.43B |
| Straumann Holding AG | 14.91B |
| Sonova Holding AG | 11.99B |